Drug Transport Mechanism of Oral Antidiabetic Nanomedicines

por Gundogdu, Evren, Yurdasiper, Aysu
Publicado 2014

Pre-clinic study of radiopharmaceutical for Covid-19 inactivation: Dose distribution with Monte Carlo Simulation

por Kilicoglu, Ozge, Kara, Umit, Ozgenc, Emre, Gundogdu, Evren
Publicado 2022

Applying Quality by Design Principles in the Development and Preparation of a New Radiopharmaceutical: Technetium-99m-Imatinib Mesylate

por Gundogdu, Evren, Demir, Emine Selin, Özgenç, Emre, Yeğen, Gizem, Aksu, Buket
Publicado 2020

Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities

por Siafaka, Panoraia I., Okur, Neslihan Üstündağ, Karantas, Ioannis D., Okur, Mehmet Evren, Gündoğdu, Evren Atlıhan
Publicado 2021

The effect of radiolabeled nanostructured lipid carrier systems containing imatinib mesylate on NIH-3T3 and CRL-1739 cells

por Gundogdu, Evren Atlihan, Demir, Emine Selin, Ekinci, Meliha, Ozgenc, Emre, Ilem Ozdemir, Derya, Senyigit, Zeynep, Asikoglu, Makbule
Publicado 2020

Radiolabeled Trastuzumab Solid Lipid Nanoparticles for Breast Cancer Cell: in Vitro and in Vivo Studies

por Ozgenc, Emre, Karpuz, Merve, Arzuk, Ege, Gonzalez-Alvarez, Marta, Sanz, Marival Bermejo, Gundogdu, Evren, Gonzalez-Alvarez, Isabel
Publicado 2022

An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake and Cytotoxicity Studies

por Gundogdu, Evren, Demir, Emine-Selin, Ekinci, Meliha, Ozgenc, Emre, Ilem-Ozdemir, Derya, Senyigit, Zeynep, Gonzalez-Alvarez, Isabel, Bermejo, Marival
Publicado 2022

Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today?

por Siafaka, Panoraia I., Okur, Mehmet Evren, Erim, Pelin Dilsiz, Çağlar, Emre Şefik, Özgenç, Emre, Gündoğdu, Evren, Köprülü, Rabia Edibe Parlar, Karantas, Ioannis D., Üstündağ Okur, Neslihan
Publicado 2022